Skincare will no longer be defined by incremental claims or new actives but by microbial science. While global players race toward breakthroughs in microbial balance, diagnostic-enabled personalization, and biotic-driven skin resilience, most innovation pipelines still rely on outdated symptom-focused models. The gap between what consumers will demand next and what current portfolios can deliver is widening.
GreyB exposes the signals shaping the next phase of microbiome-driven skincare and the strategic blind spots that will determine who captures the next category-defining opportunity.
67%
of consumers are interested in skincare products that support the skin microbiome.
~63%
growth in studies of probiotics in skin health since 2020
48%
of consumers will pay more for products that contain probiotics or prebiotics.
This Webinar Will Help You Answer
- Where are giants like L’Oréal and Unilever, and suppliers like Givaudan and DSM-Firmenich betting their future, and what gaps can you exploit before they do?
- Which startup and academic breakthroughs could bypass traditional development cycles and alter your innovation roadmap?
- What are recent patents, studies, and ingredient launches telling us about what consumers will want in the next year or two?
- Which microbiome technologies actually deserve R&D investment now?
A Deep Dive for the Teams Building The Next Generation of Microbiome-Friendly Skincare.
Register now to find out where the industry is still slow or unsure, and how you can move faster while others hesitate.
